Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.44T | 2.35T | 2.24T | 1.92T | 1.62T | 1.53T | Gross Profit |
504.09B | 497.43B | 413.32B | 404.37B | 366.42B | 332.12B | EBIT |
164.27B | 163.11B | 116.50B | 172.75B | 161.60B | 110.58B | EBITDA |
300.55B | 356.38B | 209.44B | 280.62B | 258.40B | 127.64B | Net Income Common Stockholders |
118.18B | 125.39B | 44.96B | 135.76B | 121.94B | 58.46B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
123.31B | 220.77B | 186.10B | 201.59B | 222.50B | 206.99B | Total Assets |
692.79B | 3.17T | 2.87T | 2.68T | 2.26T | 2.12T | Total Debt |
118.71B | 186.08B | 705.35B | 595.71B | 531.47B | 599.95B | Net Debt |
-4.60B | -30.92B | 519.25B | 396.06B | 311.95B | 392.96B | Total Liabilities |
291.26B | 1.50T | 1.50T | 1.36T | 1.14T | 1.15T | Stockholders Equity |
340.31B | 1.64T | 1.35T | 1.29T | 1.10T | 947.29B |
Cash Flow | Free Cash Flow | ||||
167.12B | 193.05B | -10.25B | -20.23B | 119.23B | 24.51B | Operating Cash Flow |
293.92B | 321.49B | 143.49B | 94.99B | 219.16B | 168.05B | Investing Cash Flow |
-157.74B | -153.55B | -167.72B | -116.75B | -115.16B | -318.66B | Financing Cash Flow |
-137.98B | -181.56B | -16.46B | -60.24B | -121.60B | 135.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $18.57B | 24.49 | 6.68% | 0.97% | 3.30% | 31.36% | |
74 Outperform | $102.19B | 27.46 | 20.23% | 1.48% | 7.25% | 18.36% | |
74 Outperform | $134.09B | 23.74 | 33.10% | 2.14% | 5.05% | 2.73% | |
72 Outperform | $57.46B | 24.23 | 9.66% | 2.06% | 10.29% | 22.72% | |
70 Outperform | $201.38B | 31.40 | 27.62% | 0.79% | -32.60% | -28.55% | |
69 Neutral | $27.04B | 29.76 | 26.22% | 2.14% | -11.28% | -23.69% | |
62 Neutral | $8.08B | 13.63 | 3.82% | 3.13% | 3.58% | -14.35% |